 | |||||
| lose weight | |||||
| NEWS | |||||
| Viking slips as manufacturing concerns cloud promising oral obesity drug data | Reuters Novo said in March patients lost up to 13.1% of their weight after 12 weeks while taking its experimental weight-loss pill amycretin in an early-stage ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
